Company
ALX Oncology
South San FranciscoBiotechnologyHealth CareMedicalTherapeuticsDescription
ALX Oncology announced the appointment of Alan Sandler, M.D., as Chief Medical Officer. Dr. Sandler's extensive experience in oncology and drug development, including his in-depth knowledge of ALX Oncology, makes him the ideal leader to advance the clinical development of evorpacept, the company's investigational lead compound, into late-stage clinical trials.
Quick answer
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer (November 14, 2024). ALX Oncology is based in South San Francisco, California, United States.
- What did ALX Oncology announce on November 14, 2024?
- ALX Oncology announced the appointment of Alan Sandler, M.D., as Chief Medical Officer. Dr. Sandler's extensive experience in oncology and drug development, including his in-depth knowledge of ALX Oncology, makes him the ideal leader to advance the clinical development of evorpacept, the company's investigational lead compound, into late-stage clinical trials.
- What does ALX Oncology do?
- ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives.
- Where is ALX Oncology based?
- ALX Oncology is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Grey Wolf Therapeutics (November 14, 2024), Diakonos Oncology (November 18, 2024), NRx Pharmaceuticals (November 18, 2024) and Georgiamune (November 19, 2024) also announced leadership changes within 45 days of ALX Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Greywolf Therapeutics Appoints Darlene Deptula-Hicks as Chief Financial Officer (November 14, 2024)
- Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Georgiamune Inc. Appoints Mark Avagliano as Chief Business Officer (November 19, 2024)
- neurocare Group AG Appoints Kevin Reeder as Chief Financial Officer (November 21, 2024)
- Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024)
Who to call at ALX Oncology, and when
A new leader at ALX Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ALX Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ALX Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ALX Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ALX Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ALX Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.